این سایت در حال حاضر پشتیبانی نمی شود و امکان دارد داده های نشریات بروز نباشند
Iranian Heart Journal، جلد ۲۴، شماره ۱، صفحات ۶۹-۷۷
عنوان فارسی
چکیده فارسی مقاله
کلیدواژه‌های فارسی مقاله
عنوان انگلیسی Outcomes of STEMI Complicated by Cardiogenic Shock With and Without IABP
چکیده انگلیسی مقاله Background: The results of the IABP-SHOCK II trial did not encourage the use of an intra-aortic balloon pump (IABP) in cardiogenic shock (CS) with ST-elevation myocardial infarction (STEMI). We aimed to determine whether these findings may be applicable to our population in the South Asian region, as there is a paucity of data.   Methods: In this prospective cohort study, 2 independent cohorts of STEMI patients with CS were recruited based on the utilization of IABP during revascularization. The primary endpoints of in-hospital and after 30 days of major adverse cardiac events (MACE) and the secondary endpoint of any major bleed were compared between the 2 cohorts.   Results: In total, each cohort consisted of 130 patients. Demographic, clinical, and angiographic profiles were comparable in the 2 cohorts. In the IABP and non-IABP cohorts, the in-hospital and 30-day mortality rates were 19.2% vs 26.2%; P=0.183 and 30.8% vs 36.9%; P=0.358, respectively, while the MACE rates were 20.8% vs 26.2%; P=0.306 and 32.3% vs 36.9%; P=0.434, respectively. Cardiac catheterization laboratory death was 0.8% vs 5.4%; P=0.031 and the major bleed was 4.6% vs 3.8%; P=0.758, among patients managed with IABP and without IABP, respectively.   Conclusions: Our study concluded that while there was no significant difference in the overall outcome, there was a lower trend in in-hospital mortality and significantly lower cardiac catheterization laboratory death with the use of IABP. However, the in-hospital and 30-day MACE were comparable in both groups. (Iranian Heart Journal 2023; 24(1): 69-77)
کلیدواژه‌های انگلیسی مقاله Acute myocardial infarction,Cardiogenic shock,Revascularization,IABP,MACE
نویسندگان مقاله Mahesh Kumar Batra |
National Institute of Cardiovascular Diseases (NICVD), Karachi, Pakistan.

Kamran Ahmed Khan |
National Institute of Cardiovascular Diseases (NICVD), Karachi; Pakistan.

Tahir Saghir |
National Institute of Cardiovascular Diseases (NICVD), Karachi; Pakistan.

Lajpat Rai |
National Institute of Cardiovascular Diseases (NICVD), Hyderabad, Pakistan.

Jawaid Akbar Sial |
National Institute of Cardiovascular Diseases (NICVD), Karachi, Pakistan.

Rajesh Kumar |
National Institute of Cardiovascular Diseases (NICVD), Karachi, Pakistan.

Muhammad Naeem Mengal |
National Institute of Cardiovascular Diseases (NICVD), Karachi, Pakistan.

Omer Saqib |
National Institute of Cardiovascular Diseases (NICVD), Karachi, Pakistan.

Naveedullah Khan |
National Institute of Cardiovascular Diseases (NICVD), Karachi, Pakistan.

Sanam Khowaja |
National Institute of Cardiovascular Diseases (NICVD), Karachi, Pakistan.

Nadeem Hasan Rizvi |
National Institute of Cardiovascular Diseases (NICVD), Karachi, Pakistan.

Nadeem Qamar |
National Institute of Cardiovascular Diseases (NICVD), Karachi, Pakistan.

Abdul Samad Achakzai |
National Institute of Cardiovascular Diseases (NICVD), Karachi, Pakistan.

Ashok Kumar |
National Institute of Cardiovascular Diseases (NICVD), Hyderabad, Pakistan.

Musa Karim |
National Institute of Cardiovascular Diseases (NICVD), Karachi, Pakistan.

نشانی اینترنتی http://journal.iha.org.ir/article_163881_5fa0b3abecb56294577f38f06256b89a.pdf
فایل مقاله فایلی برای مقاله ذخیره نشده است
کد مقاله (doi)
زبان مقاله منتشر شده en
موضوعات مقاله منتشر شده
نوع مقاله منتشر شده
برگشت به: صفحه اول پایگاه   |   نسخه مرتبط   |   نشریه مرتبط   |   فهرست نشریات